Lechtzin N - Search Results

1

Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.

Merlo CA, Boyle MP, Diener-West M, Marshall BC, Goss CH, Lechtzin N. Merlo CA, et al. Among authors: lechtzin n. Chest. 2007 Aug;132(2):562-8. doi: 10.1378/chest.06-2888. Epub 2007 Jul 23. Chest. 2007. PMID: 17646236

2

Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis.

Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Lechtzin N, et al. Chest. 2002 Feb;121(2):436-42. doi: 10.1378/chest.121.2.436. Chest. 2002. PMID: 11834654

3

Distraction therapy with nature sights and sounds reduces pain during flexible bronchoscopy: a complementary approach to routine analgesia.

Diette GB, Lechtzin N, Haponik E, Devrotes A, Rubin HR. Diette GB, et al. Among authors: lechtzin n. Chest. 2003 Mar;123(3):941-8. doi: 10.1378/chest.123.3.941. Chest. 2003. PMID: 12628899 Clinical Trial.

4

Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Boyle MP, et al. Among authors: lechtzin n. Am J Respir Crit Care Med. 2005 Jul 15;172(2):212-7. doi: 10.1164/rccm.200403-387OC. Epub 2005 Apr 28. Am J Respir Crit Care Med. 2005. PMID: 15860755 Free PMC article. Clinical Trial.

5

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.

Lechtzin N, John M, Irizarry R, Merlo C, Diette GB, Boyle MP. Lechtzin N, et al. Respiration. 2006;73(1):27-33. doi: 10.1159/000087686. Epub 2005 Aug 17. Respiration. 2006. PMID: 16113513

6

Supramaximal inflation improves lung compliance in subjects with amyotrophic lateral sclerosis.

Lechtzin N, Shade D, Clawson L, Wiener CM. Lechtzin N, et al. Chest. 2006 May;129(5):1322-9. doi: 10.1378/chest.129.5.1322. Chest. 2006. PMID: 16685025 Clinical Trial.

7

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.

Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Dasenbrook EC, et al. Among authors: lechtzin n. Am J Respir Crit Care Med. 2008 Oct 15;178(8):814-21. doi: 10.1164/rccm.200802-327OC. Epub 2008 Jul 31. Am J Respir Crit Care Med. 2008. PMID: 18669817

8

Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Dasenbrook EC, et al. Among authors: lechtzin n. JAMA. 2010 Jun 16;303(23):2386-92. doi: 10.1001/jama.2010.791. JAMA. 2010. PMID: 20551409

9

Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis.

West NE, Lechtzin N, Merlo CA, Turowski JB, Davis ME, Ramsay MZ, Watts SL, Stenner SP, Boyle MP. West NE, et al. Among authors: lechtzin n. Chest. 2011 Aug;140(2):469-474. doi: 10.1378/chest.10-2114. Epub 2011 Mar 10. Chest. 2011. PMID: 21393390

10

Pain is a common problem affecting clinical outcomes in adults with cystic fibrosis.

Hayes M, Yaster M, Haythornthwaite JA, Riekert KA, Nelson McMillan K, White E, Mogayzel PJ Jr, Lechtzin N. Hayes M, et al. Among authors: lechtzin n. Chest. 2011 Dec;140(6):1598-1603. doi: 10.1378/chest.11-0132. Epub 2011 Jun 9. Chest. 2011. PMID: 21659431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page